Search Results 3301-3310 of 25186 for oral

  1. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    Oral 5-aminosalicylic acid (5-ASA) compounds;; Oral corticosteroid therapy (prednisone or equivalent steroid at a dose less than or equal to [<=] 50 ...

  2. Kelly Suralik, D.M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

    Oral appliance therapy. Interests. Osseointegrated implant restorations; Dental materials science. Mayo Clinic locations. Rochester, Minnesota. Driving ...

  3. Portal Hypertension Clinical Trials - Mayo Clinic Research

    This is an Open Label, Multicenter, pilot clinical trial to assess the efficacy and safety of an oral selective Endothelin Receptor Antagonist (ambrisentan) in ...

  4. Chronic Intestinal Pseudo Obstruction de novo Clinical Outcomes Assessment

    Capable of oral nutrition (including partial oral nutrition). Currently resides in the US. Ability to read, speak, and understand English (US English) ...

  5. A One-Time DNA Study for Vasculitis - Mayo Clinic

    Nasal or oral inflammation with oral ulcers or nasal discharge with pus or blood; Abnormal chest radiograph with nodules, fixed infiltrates, or cavities ...

  6. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

    ... (oral vs rectal vs both oral and rectal); (3) role of oral budesonide in patients mild-moderate UC; (4) comparative effectiveness and tolerability of rectal ...

  7. Study Using Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms - Mayo Clinic

    We propose a phase I trial with oral curcumin + piperine in older cancer to derive a safe, optimal biological dose to be tested for stent symptoms in a future ...

  8. A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma - Mayo Clinic

    Oral prednisone at a dose of 10 mg or less per day is allowed, as are other oral corticosteroids given at glucocorticoid-equivalent doses. Topical, nasal ...

  9. Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism - Mayo Clinic

    History of hypoparathyroidism · Requirement for supplemental oral calcium treatment ≥ 1000 mg per day. · Requirement for active vitamin D therapy at a dose of ≥ ...

  10. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    Oral 5-aminosalicylic acid (5-ASA) compounds;; Oral corticosteroids (e.g., prednisone, budesonide) at a prednisone-equivalent dose of ≤ 40 mg/day or ≤ 9 mg ...